NASDAQ 
Biotech company Biogen (NASDAQ:BIIB) beat Wall Street’s revenue expectations in Q1 CY2025, with...
The U.S. Food and Drug Administration said on Friday it had cleared Fujirebio Diagnostics' blood...
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now....
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with...
On Thursday, Goldman Sachs (NYSE:GS) reaffirmed its confidence in Biogen (NASDAQ:BIIB) shares,...
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P...
On Friday, Morgan Stanley resumed coverage on Royalty Pharma stock (NASDAQ:RPRX) with an Overweight...
I will scan for these setups going forward and hopefully the trend continues. For those curious, there have been three signals over the past couple of...
The President is scheduled to sign an Executive Order on Monday to upend the entire pharmaceutical industry.
Only about 50% of S&P 500 stocks trade above their 200-day average, signaling narrow breadth even as...
